Is osteoporosis disease management cost effective?

被引:52
|
作者
Dell R. [1 ]
Greene D. [1 ]
机构
[1] Kaiser Downey, Downey, CA 90242
关键词
Bisphosphonate; Fracture; FRAX; Hip; Osteoporosis; PTH;
D O I
10.1007/s11914-010-0009-0
中图分类号
学科分类号
摘要
Can osteoporosis disease management be cost effective? To answer that question, we conducted an extensive review of osteoporosis and fragility fracture prevention literature in peer-reviewed scientific journals and evidence-based guidelines from professional societies and government health organizations. We explored different strategies suggested by the literature to find how programs can be structured to be cost effective and to decrease fracture rates. We focused on ways to cost effectively identify, risk stratify, treat, and then track patients at risk for osteoporosis and fragility fractures. Studies have shown that osteoporosis management can decrease the hip fracture rate by 25% to 50% and be cost effective at the same time. © Springer Science+Business Media, LLC 2010.
引用
收藏
页码:49 / 55
页数:6
相关论文
共 50 条
  • [1] Osteoporosis prevention and treatment in elderly men - a cost-effective strategy
    Eisman, John A.
    NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM, 2008, 4 (04): : 198 - 199
  • [2] Cost-effective osteoporosis treatment thresholds in Greece
    P. Makras
    K. Athanasakis
    N. Boubouchairopoulou
    S. Rizou
    A. D. Anastasilakis
    J. Kyriopoulos
    G. P. Lyritis
    Osteoporosis International, 2015, 26 : 1949 - 1957
  • [3] Cost-effective osteoporosis treatment thresholds in Greece
    Makras, P.
    Athanasakis, K.
    Boubouchairopoulou, N.
    Rizou, S.
    Anastasilakis, A. D.
    Kyriopoulos, J.
    Lyritis, G. P.
    OSTEOPOROSIS INTERNATIONAL, 2015, 26 (07) : 1949 - 1957
  • [4] Management of Osteoporosis in Chronic Kidney Disease
    Nitta, Kosaku
    Yajima, Aiji
    Tsuchiya, Ken
    INTERNAL MEDICINE, 2017, 56 (24) : 3271 - 3276
  • [5] Outcomes of an osteoporosis disease-management program managed by nurse practitioners
    Greene, Denise
    Dell, Richard M.
    JOURNAL OF THE AMERICAN ACADEMY OF NURSE PRACTITIONERS, 2010, 22 (06): : 326 - 329
  • [6] The cost-effectiveness of strontium ranelate in the UK for the management of osteoporosis
    F. Borgström
    O. Ström
    J. Coelho
    H. Johansson
    A. Oden
    E. McCloskey
    J. A. Kanis
    Osteoporosis International, 2010, 21 : 339 - 349
  • [7] The cost-effectiveness of strontium ranelate in the UK for the management of osteoporosis
    Borgstrom, F.
    Strom, O.
    Coelho, J.
    Johansson, H.
    Oden, A.
    McCloskey, E.
    Kanis, J. A.
    OSTEOPOROSIS INTERNATIONAL, 2010, 21 (02) : 339 - 349
  • [8] Osteoporosis, a disease of the skeleton
    Berthelemy, Stephane
    ACTUALITES PHARMACEUTIQUES, 2014, 53 (539): : 48 - 52
  • [9] The Disease Management Program Osteoporosis
    Kurth, Andreas A.
    OSTEOLOGIE, 2021, 30 (02) : 119 - 132
  • [10] The cost-effectiveness of risedronate in the UK for the management of osteoporosis using the FRAXA®
    Borgstrom, F.
    Strom, O.
    Coelho, J.
    Johansson, H.
    Oden, A.
    McCloskey, E. V.
    Kanis, J. A.
    OSTEOPOROSIS INTERNATIONAL, 2010, 21 (03) : 495 - 505